Aviva
EXEL icon

Aviva’s Exelixis EXEL Stock Holding History

Aviva’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831K Sell
15,264
-9,889
-39% -$481K ﹤0.01% 647
2026
Q1 		$1.08M Sell
25,153
-553
-2% -$23.8K ﹤0.01% 637
2025
Q4 		$1.13M Sell
25,706
-1,154
-4% -$47.7K ﹤0.01% 657
2025
Q3 		$1.11M Buy
26,860
+3,617
+16% +$145K ﹤0.01% 655
2025
Q2 		$1.02M Buy
23,243
+7,105
+44% +$284K ﹤0.01% 659
2025
Q1 		$596K Sell
16,138
-1,090
-6% -$38.8K ﹤0.01% 712
2024
Q4 		$574K Sell
17,228
-7,699
-31% -$250K ﹤0.01% 749
2024
Q3 		$647K Buy
+24,927
New +$620K ﹤0.01% 757
2021
Q2 		– Sell
-54,461
Closed -$1.23M – 903
2021
Q1 		$1.23M Buy
54,461
+5,282
+11% +$119K 0.01% 797
2020
Q4 		$987K Sell
49,179
-39,868
-45% -$835K 0.01% 864
2020
Q3 		$2.18M Sell
89,047
-11,431
-11% -$267K 0.01% 757
2020
Q2 		$2.38M Sell
100,478
-110,340
-52% -$2.56M 0.01% 593
2020
Q1 		$3.63M Buy
210,818
+96,109
+84% +$1.76M 0.03% 568
2019
Q4 		$2.02M Buy
+114,709
New +$1.94M 0.01% 700

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aviva's EXEL Position: Q2 2026 in Review

Aviva reduced its Exelixis (EXEL) stake by 39% in Q2 2026, selling an estimated $481K and leaving 15,264 shares worth $831K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Aviva first reported a position in EXEL in Q4 2019 and has held it in 14 quarters since. The position peaked at $3.63M in Q1 2020. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Aviva held 15,264 shares of Exelixis worth $831K as of Q2 2026.
  • Aviva sold 9,889 Exelixis shares in Q2 2026, an estimated $481K.
  • Exelixis made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #647 holding.
  • Aviva first reported a position in Exelixis in Q4 2019 and has held it in 14 quarters since.
  • Aviva's Exelixis position peaked at $3.63M in Q1 2020.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.